000 | 01350 a2200421 4500 | ||
---|---|---|---|
005 | 20250515123116.0 | ||
264 | 0 | _c20080707 | |
008 | 200807s 0 0 eng d | ||
022 | _a0301-0430 | ||
024 | 7 |
_a10.5414/cnp69347 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChen, H-H | |
245 | 0 | 0 |
_aIncreased erythropoietin-alpha dose when switching from subcutaneous to intravenous administration: effect of serum albumin. _h[electronic resource] |
260 |
_bClinical nephrology _cMay 2008 |
||
300 |
_a347-53 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aEpoetin Alfa |
650 | 0 | 4 |
_aErythropoietin _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFerritins _xblood |
650 | 0 | 4 | _aHematocrit |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInjections, Intravenous |
650 | 0 | 4 | _aInjections, Subcutaneous |
650 | 0 | 4 |
_aKidney Failure, Chronic _xblood |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aRecombinant Proteins |
650 | 0 | 4 | _aRenal Dialysis |
650 | 0 | 4 |
_aSerum Albumin _xanalysis |
650 | 0 | 4 |
_aTransferrin _xanalysis |
700 | 1 | _aTarng, D-Ch | |
700 | 1 | _aWu, Ch-J | |
700 | 1 | _aChen, Y-W | |
700 | 1 | _aTing, J-T | |
773 | 0 |
_tClinical nephrology _gvol. 69 _gno. 5 _gp. 347-53 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.5414/cnp69347 _zAvailable from publisher's website |
999 |
_c18023929 _d18023929 |